An international team led by the Clínic-IDIBAPS-UB along with the Institute of Cancer Research, London, has developed a new method based on DNA methylation to decipher the origin and evolution of cancer, which makes it possible to predict its future clinical course. The study, published today in the journal Nature, analyzes the evolution of the tumors of 2,000 patients with leukemias and lymphomas.
Go to Source
https://medicalxpress.com/rss-feed/